| RILPIVIRINE |
205302 |
001 |
ANDA |
RILPIVIRINE |
TABLET;ORAL |
25MG |
No
|
No
|
2015/09/29
(TA)
|
--
|
STRIDES ARCOLAB LTD |
None (Tentative Approval) |
| EMTRICITABINE; RILPIVIRINE; TENOFOVIR ALAFENAMIDE |
214058 |
001 |
ANDA |
EMTRICITABINE;RILPIVIRINE;TENOFOVIR ALAFENAMIDE |
TABLET;ORAL |
200MG;25MG;25MG |
No
|
No
|
2022/09/27
(TA)
|
--
|
CIPLA LIMITED |
None (Tentative Approval) |
| DOLUTEGRAVIR; RILPIVIRINE |
213120 |
001 |
ANDA |
DOLUTEGRAVIR;RILPIVIRINE |
TABLET;ORAL |
50MG/25MG |
No
|
No
|
2023/01/13
(TA)
|
--
|
LUPIN LTD |
None (Tentative Approval) |
| EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE |
208452 |
001 |
ANDA |
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE |
TABLET;ORAL |
200MG;EQ 25MG BASE;300MG |
No
|
No
|
2025/05/20
|
2025/05/20
|
MYLAN |
Prescription |
| RILPIVIRINE |
218798 |
002 |
ANDA |
RILPIVIRINE |
TABLET |
2.5MG |
No
|
No
|
2025/08/20
(TA)
|
--
|
SOMERSET THERAPEUTICS, LLC |
None (Tentative Approval) |